The bacterial flora in inflammatory bowel disease: current insights in pathogenesis and the influence of antibiotics and probiotics.
about
Dysbiosis in inflammatory bowel diseaseMechanisms and therapeutic effectiveness of lactobacilliNutritional protective mechanisms against gut inflammationResearch Advance in Intestinal Mucosal Barrier and Pathogenesis of Crohn's DiseaseLower Level of Bacteroides in the Gut Microbiota Is Associated with Inflammatory Bowel Disease: A Meta-AnalysisBacterial and fungal microbiota in relation to probiotic therapy (VSL#3) in pouchitis.Mucosa-associated bacterial diversity in relation to human terminal ileum and colonic biopsy samplesHeat shock protein-derived T-cell epitopes contribute to autoimmune inflammation in pediatric Crohn's disease.In case of obesity, longevity-related mechanisms lead to anti-inflammation.Pathogenesis of Afa/Dr diffusely adhering Escherichia coli.Eubacterium limosum ameliorates experimental colitis and metabolite of microbe attenuates colonic inflammatory action with increase of mucosal integrity.Alternative medicines as emerging therapies for inflammatory bowel diseases.Enterocyte cytoskeleton changes are crucial for enhanced translocation of nonpathogenic Escherichia coli across metabolically stressed gut epithelia.Quantification of intestinal bacterial populations by real-time PCR with a universal primer set and minor groove binder probes: a global approach to the enteric flora.Association of gut microbiota with post-operative clinical course in Crohn's disease.Analysis of gene expression in ceca of Helicobacter hepaticus-infected A/JCr mice before and after development of typhlitis.Different Dynamic Patterns of β-Lactams, Quinolones, Glycopeptides and Macrolides on Mouse Gut Microbial DiversityThe immunology of the vermiform appendix: a review of the literature.Intestinal microvascular endothelium and innate immunity in inflammatory bowel disease: a second line of defense?A prospective, randomized, blinded, placebo-controlled pilot study on the effect of Enterococcus faecium on clinical activity and intestinal gene expression in canine food-responsive chronic enteropathy.Efficacy profiles for different concentrations of Lactobacillus acidophilus in experimental colitisOral Administration of Interleukin-10 and Anti-IL-1 Antibody Ameliorates Experimental Intestinal Inflammation.Intestinal barrier dysfunction in human necrotizing enterocolitis.Paediatric inflammatory bowel disease: a mechanistic approach to investigate exclusive enteral nutrition treatment.Personalizing protein nourishmentDendritic cells and the intestinal bacterial flora: a role for localized mucosal immune responsesNOD2 (CARD15) mutations in Crohn's disease are associated with diminished mucosal alpha-defensin expressionKefir treatment ameliorates dextran sulfate sodium-induced colitis in rats.Inflammatory bowel disease therapies and gut function in a colitis mouse model.Bifidobacterium lactis attenuates onset of inflammation in a murine model of colitis.Escherichia coli Nissle 1917 distinctively modulates T-cell cycling and expansion via toll-like receptor 2 signaling.Effects of probiotic on intestinal mucosa of patients with ulcerative colitis.Potential Synergies of β-Hydroxybutyrate and Butyrate on the Modulation of Metabolism, Inflammation, Cognition, and General Health.Increased expression of Toll-like receptor (TLR) 2 and TLR4 in the colonic mucosa of children with inflammatory bowel disease
P2860
Q24685931-B000F079-91AB-4D71-BBB1-5AA382A167B1Q27012999-D7741223-07E5-49A5-9E37-7D92DA8E9EC2Q27028202-289E5D8D-3BDD-497E-9E5B-B7ADAC4DFD34Q28066444-96B9EA07-43F5-4440-87D1-D11B6F7B4E9CQ28069071-1B22E37C-B1AF-4C0A-AF4E-418BAC89DA7BQ33231186-EE1D35EE-5050-40DF-A757-B48FAC253504Q33300047-0E08B380-DB0C-4512-9B8A-48F56D5FC430Q33514815-BEBE5EA6-E785-4FDE-BC43-F603FFA407DBQ33689066-CC6688EC-34EC-486F-9D3F-3016D7B57623Q33755215-9B518F95-264B-48A9-A668-C09CFCB17649Q33868123-69F6CA89-7342-4F5B-B1D2-391F1902A27AQ34069427-BD68AF4B-0385-4587-98F7-025135D5BEB7Q34300900-FF43B542-7238-4331-AAD2-DEA2130853DFQ34780290-736EB9B8-60CD-4587-AEC1-0A73D6F727B9Q34960634-714B661B-F287-4427-90A2-0033EF5463A1Q35106581-FD4C3B91-C396-4FEA-8BAF-9E76E19CFB79Q35603063-B8FAD9E9-4465-44A0-81A9-1CE0C5DFD86BQ36043624-09B65F12-0649-4929-84F8-60BD6A6772C9Q36599369-2B4F19D5-B91A-4BA0-BC64-C84FCCAF11D4Q36975121-DC500654-4FE9-4584-9794-A0909063010CQ37118873-B8C7C7CF-54B8-435C-AE82-2F70D744C624Q37358329-C76A0BB6-028B-4093-ADAD-4974EB9322CBQ37594657-F0357062-AA29-4EEF-A681-DC5CFBB42EFDQ38223408-F17F6D93-AFF5-4405-8817-40698F418664Q38682079-4DEE8C84-6E7F-4D32-BE41-306531425E15Q39857956-8F38B111-01D7-4C31-96CF-92558CB8B68BQ41917631-DF51472C-355E-49E8-959B-9F1D7B48D163Q42004558-7A4956D7-E1CA-4B89-9AF2-537A1B2C7492Q42288030-CE01C70E-A195-4388-B417-EE4FE626C257Q42580341-019E8D13-86B1-4EC1-BBC6-6E1344330BEEQ42704864-401FF22B-81C3-417B-9782-CBEE05CAA3BCQ43159889-BDB161C9-A153-4DC8-9059-2AEF3021AF81Q55114436-D033A611-1DB5-4F77-89D1-E6C45B35E549Q58763371-FD400FAB-7646-452D-9F4E-CE8D7D1C5AD2
P2860
The bacterial flora in inflammatory bowel disease: current insights in pathogenesis and the influence of antibiotics and probiotics.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
The bacterial flora in inflamm ...... of antibiotics and probiotics.
@ast
The bacterial flora in inflamm ...... of antibiotics and probiotics.
@en
The bacterial flora in inflamm ...... of antibiotics and probiotics.
@nl
type
label
The bacterial flora in inflamm ...... of antibiotics and probiotics.
@ast
The bacterial flora in inflamm ...... of antibiotics and probiotics.
@en
The bacterial flora in inflamm ...... of antibiotics and probiotics.
@nl
prefLabel
The bacterial flora in inflamm ...... of antibiotics and probiotics.
@ast
The bacterial flora in inflamm ...... of antibiotics and probiotics.
@en
The bacterial flora in inflamm ...... of antibiotics and probiotics.
@nl
P2093
P1476
The bacterial flora in inflamm ...... of antibiotics and probiotics.
@en
P2093
Huijsdens XW
Linskens RK
Meuwissen SG
Savelkoul PH
Vandenbroucke-Grauls CM
P577
2001-01-01T00:00:00Z